Glympse Bio
Cambridge, US · Founded 2015 · Delaware corporation · 9 known investors
Biotech
Founders & leadership
Glympse Bio was founded in 2015 by Gabriel Kwong.
GK
Gabriel KwongFounder
SR
Sirshendu Roopom BanerjeeExecutive
Board
TG
Theresia GuowBoard director
AS
SL
Stan LapidusBoard director
Investors · 9
GreatPoint VenturesSan Francisco · $250K – $20M
Acrew CapitalreportedSan Francisco · $1M – $15Mvia Theresia Gouw · board
Aspect VenturesreportedPalo Altovia Theresia Gouw · board
Catalio Capital ManagementreportedNew York
Dns CapitalreportedChicago · $25M – $100M
New Leaf Venture PartnersreportedNew York
Polaris PartnersreportedBoston · $500K – $5Mvia Amy Schulman · board
Section 32reportedPalo Alto
TemasekreportedSingapore
Reported raises · per SEC filings
Form D private placements$114M disclosed across 4 rounds · 2018–2023
▶$23.2MraisedMay 2023 · 10 investors · BiotechnologyRule 506(b)
▶$23.2MraisedMay 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ALEXANDRA CANTLEYDirector
- STANLEY LAPIDUSDirector
- JOHN MCDONOUGHDirector
- YINGMIN WANGDirector
- HUILIN SHAODirector
- STEVE KAFKADirector
- Offering amount
- $23.2M
- Amount sold
- $23.2M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MraisedDec 2021 · 12 investors · BiotechnologyRule 506(b)
▶$18MraisedDec 2021 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Caroline LoewExecutive Officer, Director
- Theresia GouwDirector
- Amy SchulmanDirector
- Stanley LapidusDirector
- Robert LangerDirector
- Francis CussDirector
- Tram TranExecutive Officer
- Steve KafkaDirector
- Wendy Winckler AdamovichExecutive Officer
- Jessica AtkinsonExecutive Officer
- Dhaval GosaliaExecutive Officer
- Matthew NavarroExecutive Officer
- George ZacharyDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$46.7MraisedJul 2021 · 19 investors · BiotechnologyRule 506(b)
▶$46.7MraisedJul 2021 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Theresia GouwDirector
- Jessica AtkinsonExecutive Officer
- Amy SchulmanDirector
- Steve KafkaDirector
- Stanley LapidusDirector
- Francis CussDirector
- Dhaval GosaliaExecutive Officer
- Robert LangerDirector
- George ZacharyDirector
- Wendy Winckler AdamovichExecutive Officer
- Caroline LoewExecutive Officer, Director
- Offering amount
- $46.7M
- Amount sold
- $46.7M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.1MraisedAug 2018 · 17 investors · BiotechnologyRule 506(b)
▶$26.1MraisedAug 2018 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Theresia GuowDirector
- Sirshendu Roopom BanerjeeExecutive Officer
- Gabriel KwongExecutive Officer
- Stan LapidusDirector
- Amy SchulmanDirector
- Offering amount
- $30.1M
- Amount sold
- $26.1M
- Proceeds to insiders
- $900K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Glympse Bio went on to found or lead other companies.
In the news
Frequently asked questions
- Who founded Glympse Bio?
- Glympse Bio was founded by Gabriel Kwong in 2015.
- Who are Glympse Bio's investors?
- Glympse Bio's investors include GreatPoint Ventures, Acrew Capital, Aspect Ventures, Catalio Capital Management, Dns Capital, New Leaf Venture Partners, Polaris Partners, Section 32 and 1 more.
- How much funding has Glympse Bio raised?
- Glympse Bio has disclosed $114M raised across 4 rounds.
- Where is Glympse Bio headquartered?
- Glympse Bio is headquartered in Cambridge, US.